Trial Profile
Efficacy of Alectinib in patients with non small cell lung cancer after failure with Ceritinib: a retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Alectinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Nov 2017 New trial record
- 01 Nov 2017 Results (n=8) published in the Anticancer Research.